Dashboard
Manage Tickers

LABPLandos Biopharma, Inc.

Nasdaq landosbiopharma.com


$ 22.15 $ -0.04 (-0.19 %)    

Thursday, 02-May-2024 15:59:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.06 $ 2.63 (0.61 %)
DIA $ 386.38 $ 3.97 (1.04 %)
SPY $ 510.55 $ 0.02 (0 %)
TLT $ 89.64 $ -0.47 (-0.52 %)
GLD $ 212.59 $ -0.83 (-0.39 %)
$ 22.25
$ 22.15
$ 21.91 x 1,000
$ 0.00 x 0
$ 22.15 - $ 22.15
$ 2.50 - $ 22.84
6,316
na
139.64M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-24-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 07-29-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ex-humira-growth-platform-drives-abbvies-q1-performance-drugmaker-lifts-annual-profit-outlook
Ex-Humira Growth Platform Drives AbbVie's ...
04/26/2024 13:54:00

AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immun...

hc-wainwright--co-downgrades-landos-biopharma-to-neutral-lowers-price-target-to-2042
HC Wainwright & Co. Downgrades Landos Biop...
04/01/2024 11:12:42

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Landos Biopharma (NASDAQ:LABP) from Buy to Neutral and lowers ...

nasdaq-turns-higher-akanda-shares-plunge
Nasdaq Turns Higher; Akanda Shares Plunge
03/25/2024 19:00:39

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0....

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/25/2024 17:30:58

crude-oil-moves-higher-us-new-home-sales-fall-in-february
Crude Oil Moves Higher; US New Home Sales ...
03/25/2024 15:54:41

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow trad...

why-is-ulcerative-colitis-focused-landos-biopharma-stock-trading-higher-on-monday
Why Is Ulcerative Colitis-Focused Landos B...
03/25/2024 15:27:58

AbbVie seals deal with Landos Biopharma at $20.42/share, totaling $137.5 million plus CVR. Acquisition targets NX-13, promising...

us-stocks-down-chicago-fed-national-activity-index-rises-in-february
US Stocks Down; Chicago Fed National Activ...
03/25/2024 13:42:15

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday. Following the market op...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
03/25/2024 13:05:53

Core News & Articles
AbbVie To Acquire Landos Biopharma At A Pr...
03/25/2024 12:32:12

AbbVie Inc. (NYSE:ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ:LABP) ("Landos") today announced a defini...

trading-halt-halted-at-82500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:25:00 a.m. ET - ...
03/25/2024 12:25:04

recap-landos-biopharma-q4-earnings
Recap: Landos Biopharma Q4 Earnings
03/21/2024 13:40:05

landos-biopharma-q4-eps-099-misses-091-estimate-cash-balance-of-375m
Landos Biopharma Q4 EPS $(0.99) Misses $(0...
03/21/2024 12:06:40

Landos Biopharma (NASDAQ:LABP) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(...

landos-biopharma-to-present-new-data-on-immunometabolism-at-the-19th-annual-congress-of-the-european-crohns-and-colitis-organisation
Landos Biopharma To Present New Data On Im...
01/08/2024 13:26:24

Landos Biopharma, Inc. (NASDAQ:LABP) ("Landos" or the "Company"), a clinical-stage biopharmaceutical company de...

landos-biopharma-publishes-results-of-nx-13-phase-1b-study-in-ulcerative-colitis-in-journal-of-crohns-and-colitis
Landos Biopharma Publishes Results Of NX-1...
11/21/2023 13:02:55

landos-biopharma-q3-eps-094-misses-088-estimate
Landos Biopharma Q3 EPS $(0.94) Misses $(0...
11/09/2023 13:27:13

Landos Biopharma (NASDAQ:LABP) reported quarterly losses of $(0.94) per share which missed the analyst consensus estimate of $(...

landos-biopharma-q3-earnings-insights
Landos Biopharma: Q3 Earnings Insights
11/09/2023 13:10:12

landos-biopharma-to-present-new-data-on-nx-13-from-phase-1b-trial-in-ulcerative-colitis-at-united-european-gastroenterology-week-2023-congress
Landos Biopharma To Present New Data On NX...
09/19/2023 12:14:32

NX-13 Demonstrated Rapid Symptomatic Relief and Improvement in Multiple Biomarkers that Correlated With Early Endoscopic Respon...

landos-biopharma-enters-strategic-research-collaboration-with-ku-leuven-and-university-hospitals-leuven-to-further-characterize-effects-of-nx-13-on-epithelial-cells
Landos Biopharma Enters Strategic Research...
09/14/2023 12:03:20

Recruitment, screening and randomization of patients continues, with top-line results on track for the fourth quarter of 2024. ...

landos-biopharma-q2-eps-063-up-from-280-yoy
Landos Biopharma Q2 EPS $(0.63) Up From $(...
08/09/2023 12:28:37

Landos Biopharma (NASDAQ:LABP) reported quarterly losses of $(0.63) per share. This is a 77.5 percent increase over losses of $...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION